- Home
- ADRX vs INVA Comparison
ADRX vs INVA Comparison
Compare ADRX & INVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
N/A
Current Price
$17.37
HOLD
Current Price
$20.63
Company Overview
Basic Information| Metric | ADRX | INVA |
|---|---|---|
| Founded | 2019 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.1B | 1.7B |
| IPO Year | 2026 | 2000 |
Fundamental Metrics
Financial Performance| Metric | ADRX | INVA |
|---|---|---|
| Price | $17.37 | $20.63 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 4 | 5 |
| Target Price | $35.00 | $35.00 |
| AVG Volume (30 Days) | 487.3K | ★ 619.0K |
| Earning Date | 11-15-2026 | 11-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 816.67 |
| EPS | N/A | ★ 1.25 |
| Revenue | N/A | ★ $217,217,000.00 |
| Revenue This Year | N/A | $9.72 |
| Revenue Next Year | N/A | $8.58 |
| P/E Ratio | ★ N/A | $16.86 |
| Revenue Growth | N/A | ★ 62.63 |
| 52 Week Low | $16.61 | $17.45 |
| 52 Week High | $19.57 | $25.15 |
Technical Indicators
Market Signals| Indicator | ADRX | INVA |
|---|---|---|
| Relative Strength Index (RSI) | 39.56 | 44.28 |
| Support Level | $16.85 | $20.43 |
| Resistance Level | $18.99 | $21.69 |
| Average True Range (ATR) | 1.24 | 0.46 |
| MACD | -0.06 | -0.01 |
| Stochastic Oscillator | 16.92 | 0.75 |
Price Performance
Historical Comparison ADRX
INVA
About INVA Innoviva Inc.
Innoviva Inc is a company with a portfolio of royalty healthcare assets. It has three primary sets of assets: a royalty portfolio, operating assets in critical care and infectious disease, and other strategic healthcare assets. Its product offering includes Relvar/Breo/Ellipta, Anoro, Trelegy, and others.